Myositis-Associated Autoantibodies in Patients With Juvenile Myositis Are Associated With Refractory Disease and Mortality.
Matthew A ShermanPayam Noroozi FarhadiKatherine PakEdward P TrieuKakali SarkarIra N TargoffMegan L NeelyAndrew Lee MammenLisa G Ridernull nullPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
MAAs were prevalent in a large cohort of patients with juvenile myositis. ILD, refractory disease, and mortality were associated with MAA positivity. Prospective studies are needed to determine whether early detection of MAAs may lead to improved outcomes for patients with juvenile myositis.